Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Divergent trajectories of antiviral memory after SARS-CoV-2 infection

Title: Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Authors: Tomic, A; Skelly, DT; Ogbe, A; O'Connor, D; Pace, M; Adland, E; Alexander, F; Ali, M; Allott, K; Azim Ansari, M; Belij-Rammerstorfer, S; Bibi, S; Blackwell, L; Brown, A; Brown, H; Cavell, B; Clutterbuck, EA; de Silva, T; Eyre, D; Lumley, S; Flaxman, A; Grist, J; Hackstein, C-P; Halkerston, R; Harding, AC; Hill, J; James, T; Jay, C; Johnson, SA; Kronsteiner, B; Lie, Y; Linder, A; Longet, S; Marinou, S; Matthews, PC; Mellors, J; Petropoulos, C; Rongkard, P; Sedik, C; Silva-Reyes, L; Smith, H; Stockdale, L; Taylor, S; Thomas, S; Tipoe, T; Turtle, L; Vieira, VA; Wrin, T; Pollard, AJ; Lambe, T; Frater, J; Mentzer, AJ; James, WS; Barnes, E; Dunachie, SJ
Contributors: Group, OPTIC Clinical; Group, PITCH Study
Publisher Information: Springer Nature
Publication Year: 2022
Collection: Oxford University Research Archive (ORA)
Description: The trajectories of acquired immunity to severe acute respiratory syndrome coronavirus 2 infection are not fully understood. We present a detailed longitudinal cohort study of UK healthcare workers prior to vaccination, presenting April-June 2020 with asymptomatic or symptomatic infection. Here we show a highly variable range of responses, some of which (T cell interferon-gamma ELISpot, N-specific antibody) wane over time, while others (spike-specific antibody, B cell memory ELISpot) are stable. We use integrative analysis and a machine-learning approach (SIMON - Sequential Iterative Modeling OverNight) to explore this heterogeneity. We identify a subgroup of participants with higher antibody responses and interferon-gamma ELISpot T cell responses, and a robust trajectory for longer term immunity associates with higher levels of neutralising antibodies against the infecting (Victoria) strain and also against variants B.1.1.7 (alpha) and B.1.351 (beta). These variable trajectories following early priming may define subsequent protection from severe disease from novel variants.
Document Type: article in journal/newspaper
Language: English
DOI: 10.1038/s41467-022-28898-1
Availability: https://doi.org/10.1038/s41467-022-28898-1; https://ora.ox.ac.uk/objects/uuid:229c3c98-fcb6-4e98-a612-e9b8d2b02391
Rights: info:eu-repo/semantics/openAccess ; CC Attribution (CC BY)
Accession Number: edsbas.3A3143B2
Database: BASE